The toxicology and characteristics of fatal new psychoactive stimulant and hallucinogen-related poisonings in Australia, 2000–2025

Read full text Summarise with VIRAT
Authors: Shane G Darke, Johan A Duflou, Michael Farrell, Julia Lappin, Amy Peacock
Cited by: 0
References: 19

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

New psychoactive stimulants and hallucinogens (NPSH) poisonings have generated considerable public health concern in recent years. We aimed to determine: 1. The characteristics, toxicology and major autopsy findings of known cases of NBZD-related poisoning in Australia, 2000-2025; and 2. Changes in characteristics of known cases from 2020 onwards compared to earlier known cases. Retrospective study of fatal NPSH-related poisonings in Australia retrieved from the National Coronial Information System. 70 cases were identified, the first occurring in 2007. In 22.9% the decedent appeared unaware they were consuming a NPHS, and in 32.9% the NPSH had been injected. The most commonly observed signs and symptoms of acute NPSH poisoning were intense agitation (22.9%), sudden collapse (22.9%) and hyperthermia (20.0%). There were 31 NPSH identified, of which 13 were first detected in the 2020 s. The most commonly detected NPSH were cathinones (48.6%), most frequently α-pyrrolidinovalerophenone and methylenedioxypyrovalerone. Phenethylamines were present in 38.6%, with paramethoxymethamphetamine and a range of the N-benzylphenethylamine series ( NBOMe) the most common. Tryptamines were present in 18.6%, and three cases involved piperazines. In 18 cases (25.7%) multiple NPSH were detected in the blood. 2020 s cases were more likely to have tryptamines detected (36.7 v 5.0%), but less likely to have phenethylamines (23.3 v 50.0%). Psychoactive drugs in addition to NPSH were present in 92.9%, most commonly psychostimulants (68.6%) and hypnosedatives (40.0%). A wider range of NPHS have been detected in recent fatal poisonings, with tryptamines becoming more common in the 2020 s, and phenethylamines less common. • 70 fatal toxicity cases involving new psychoactive stimulants/hallucinogens (NPSH) • 31 NPSH identified, of which 13 were first detected in the 2020 s • The most commonly detected NPSH were cathinones (48.6%) • In 18 cases (25.7%) multiple NPSH were detected in the blood • In 16 cases the decedent appeared unaware they were consuming a NPHS

Fields of Study & Subjects

Forensic Toxicology and Drug Analysis Poisoning and overdose treatments Historical and Scientific Studies

Publication details

Journal / source
Drug and Alcohol Dependence Reports
Volume
19
Pages
100434–100434
Publication date
22 March 2026
Language
EN